Join Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) for an R&D day in New York City to discuss its neurological and rare diseases pipeline on Wednesday, June 25, 2025 at 8:30 AM ET.

The event will feature members of Acadia’s management team and R&D organization, key opinion leaders (KOL) and members of the caregiver community.

A replay of Acadia’s R&D Day will be available on the company’s website, acadia.com, under the investors section for approximately 3 months following the event.